Deliver Your News to the World

Physician Preferences Define Fixationless Vaginal Sling Market


August 11, 2005—Fixationless vaginal slings are recognized as the gold standard treatment for urinary incontinence (UI), a condition that afflicts millions of women worldwide. UI can have dramatic psychological repercussions, affecting daily routines and personal relationships. Demand for minimally invasive UI treatments and the expedient operating times and high efficacy rates these devices offer, continues to drive the global adoption of fixationless vaginal slings. Innovation has produced an onslaught of new products and competitors over the past 4 years, fueling a global fixationless sling market set to surpass $200 million by 2006. Manufacturers must possess a thorough understanding of the preferences and attitudes of gynecologists and urologists in order to effectively market fixationless slings in an increasingly competitive global market.

In a newly published report by Millennium Research Group (MRG), over 200 urologists and gynecologists from around the world identify the product characteristics, clinical factors, and vendor criteria that inform their fixationless sling usage patterns. The report reveals that while urologists and gynecologists perform a similar volume of vaginal sling procedures each month, gynecologists use fixationless products with greater frequency. Despite an increased adoption of transobturator slings, urologists and gynecologists also indicated that the availability of a vaginal or transvaginal approach remains the most important characteristic governing the selection of a fixationless sling. Respondents further identified ease-of-use and associated infection rates as crucial determinates of product satisfaction.

MRG’s Global Urologist and Gynecologist Survey 2005: Fixationless Vaginal Sling Adoption & Usage Patterns examines respondent preferences concerning fixationless vaginal slings offered by 14 suppliers, including Johnson & Johnson (JNJ), American Medical Systems (AMMD), Mentor Corporation (MNT), Bard Urological (BCR), and Boston Scientific (BSX).

A leading source of competitive intelligence, MRG is now the largest provider of medical device market research in the world. Located in Toronto, Canada, MRG covers global markets and has pioneered reporting of numerous emerging products.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.